National Comprehensive Cancer Network announces collaboration with blood cancer experts in Poland
New international agreement builds on existing work to improve cancer care and outcomes worldwide by adapting and implementing evidence-based guidelines for Poland and beyond
2023-02-27
(Press-News.org) PLYMOUTH MEETING, PA [February 27, 2023] — Today, the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading United States cancer centers—announced a new collaboration with the Institute of Hematology and Transfusion Medicine in Poland (IHIT), and the Alliance For Innovation—Polish-American Foundation (AFI). The three organizations have signed an agreement enabling clinicians to share their established expertise and international experience in order to improve quality of care and outcomes for patients with hematologic malignancies in Poland and around the world.
“This new agreement highlights our commitment to continue advancing our ongoing collaboration with Polish colleagues to standardize and improve how cancers are managed,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “The Institute of Hematology and Transfusion Medicine in Poland is the leading medical and research hospital in Poland for hematology; it serves as a national clinical and diagnostic reference center. Together, we can make sure more people with blood cancers receive region-appropriate treatment based on the latest evidence and expert consensus.”
This new agreement builds on a multi-year collaboration between NCCN, the Marie Curie-Sklodowska National Research Institute of Oncology, Republic of Poland Ministry of Health, and AFI to improve country-specific guidelines for solid tumor diagnostic and therapeutic procedures in Poland, based on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) —as called for in Poland’s National Cancer Strategy. NCCN Guidelines® are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. They have been translated, adapted, and harmonized in collaboration with local and regional experts, advocates, and policymakers across Sub-Saharan Africa, the Middle East and North Africa (MENA), the Caribbean, Asia, South America, and Europe, in order to make them more relevant and accessible to patients and care providers worldwide. The initial work with Poland launched in 2021; to date, the groups have co-developed Polish NCCN Guidelines Adaptations for:
Central Nervous System Cancers,
Cervical Cancer,
Colon Cancer,
Head and Neck Cancers, and
Ovarian Cancer
“Our main goal is to improve the quality of care and outcomes for hematologic patients in Poland,” said Prof. Ewa Lech-Marańda, Director of the IHIT. “The cooperation between our institutions will include the development of adapted clinical guidelines based on NCCN’s knowledge, experience, and expertise, as well as longstanding procedures for continuous updates.”
“The signing of an agreement between such important cancer control institutions is of great importance for patients and the oncological community, as well as for the further development of Polish-American cooperation,” said Marcin Hańczaruk, Co-Chairman of AFI.
NCCN’s resources for cancer patients and providers are widely accessed and utilized free-of-charge around the world. Nearly half of the 1.7 million registered users who view NCCN Guidelines at NCCN.org or via the Virtual Library of NCCN Guidelines® app are located outside of the U.S. Learn more about NCCN’s collaborative work to define and advance high-quality, high-value, patient-centered cancer care globally at NCCN.org/global.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-02-27
MINNEAPOLIS – Black people are receiving medications for dementia less often than white people, according to a preliminary study released today, February 26, 2023, that will be presented at the American Academy of Neurology’s 75th Annual Meeting being held in person in Boston and live online from April 22-27, 2023.
“Previous research has shown that due to racial disparities, people with dementia do not always receive the same access to medications that may be beneficial in nursing homes and hospitals,” said Alice Hawkins, MD, of Mount Sinai in New York, New York, and a member of the ...
2023-02-27
Three years into a five-year pledge to completely phase out lead shot in UK game hunting, a Cambridge study finds that 94% of pheasants on sale for human consumption were killed using lead.
The pledge, made in 2020 by nine major UK game shooting and rural organisations, aims to protect the natural environment and ensure a safer supply of game meat for consumers. Lead is toxic even in very small concentrations, and discarded shot from hunting poisons and kills tens of thousands of the UK’s wild birds each year.
A Cambridge-led team of 17 volunteers bought whole pheasants from butchers, game ...
2023-02-25
“Although contracting herpes simplex or herpes zoster is unpleasant, the mechanism by which these herpesvirus infections can produce a therapeutic effect […]”
BUFFALO, NY- February 24, 2023 – A new editorial was published in Genes & Cancer on January 19, 2023, entitled, “Severe herpesvirus infection beats adult T-cell leukemia/lymphoma.”
In this recently published editorial, researcher Tatsuro Jo from the Japanese Red Cross Nagasaki Genbaku Hospital’s Department of Hematology discussed aggressive type adult T-cell ...
2023-02-25
Octopus arms coordinate nearly infinite degrees of freedom to perform complex movements such as reaching, grasping, fetching, crawling, and swimming. How these animals achieve such a wide range of activities remains a source of mystery, amazement, and inspiration. Part of the challenge comes from the intricate organization and biomechanics of the internal muscles.
This problem was tackled in a multidisciplinary project led by Prashant Mehta and Mattia Gazzola, professors of mechanical science & engineering at the University of Illinois ...
2023-02-25
As the mental health crisis continues across the nation, many people struggle to find the care they need. Health insurers publish directories of mental health providers to help consumers obtain care; however, inaccurate directories and a shortage of providers within many insurance networks can make finding covered mental health services challenging.
The U.S. federal government and those of many states have put regulations in place to ensure provider directory accuracy, with California having some of the most stringent rules. However, research on the accuracy of mental health care provider directories has been limited. Simon Haeder, PhD, associate ...
2023-02-25
UNIVERSITY PARK, Pa. — Workers tasked with moving products in the immense U.S. food system are at a high risk of serious injury, according to a new Penn State-led study, and pandemic-caused, supply-chain problems have worsened the situation, researchers suggest.
The modern food supply chain presents unique hazards to employees that result in higher rates of death and injury when compared to most other industries, noted lead researcher Judd Michael, Penn State professor of agricultural and biological engineering. ...
2023-02-25
BOSTON – As legislation in multiple states eases former restrictions around medical and recreational cannabis in the United States, an increasing proportion of the population reports use of the drug. Between 2016 and 2018, more than 22 percent of Massachusetts residents reported any prior cannabis use for medical or recreational reasons. However, little is known about cannabis use in patients who undergo surgery or interventional procedures, where cannabis use has important additional clinical implications.
In a new study published in The Lancet’s eClinical Medicine, researchers led ...
2023-02-25
UNIVERSITY PARK, Pa. — Perovskites, a family of materials with unique electric properties, show promise for use in a variety fields, including next-generation solar cells. A Penn State-led team of scientists created a new process to fabricate large perovskite devices that is more cost- and time-effective than previously possible and that they said may accelerate future materials discovery.
“This method we developed allows us to easily create very large bulk samples within several minutes, rather than days or weeks using traditional methods,” said Luyao Zheng, a postdoctoral researcher in the Department of Materials Science at Penn State and lead author on the ...
2023-02-25
Washington — PETA scientists have just released a new edition of the groundbreaking Research Modernization Deal (RMD), the world’s first comprehensive plan for phasing out the use of animals in experimentation. The update is packed with new, cutting-edge information and reflects the latest scientific developments and regulatory changes since the RMD was first introduced in 2018.
The RMD provides detailed information about the pressing need to transition toward human-relevant research, and this new edition outlines non-animal methods for studying COVID-19. It also ...
2023-02-25
Excess weight or obesity boosts risk of death by anywhere from 22% to 91%—significantly more than previously believed—while the mortality risk of being slightly underweight has likely been overestimated, according to new CU Boulder research.
The findings, published Feb. 9 in the journal Population Studies, counter prevailing wisdom that excess weight boosts mortality risk only in extreme cases.
The statistical analysis of nearly 18,000 people also shines a light on the pitfalls of using ...
LAST 30 PRESS RELEASES:
[Press-News.org] National Comprehensive Cancer Network announces collaboration with blood cancer experts in Poland
New international agreement builds on existing work to improve cancer care and outcomes worldwide by adapting and implementing evidence-based guidelines for Poland and beyond
